Hashimoto’s hypothyroidism and nail cancer are not the same disease. Hashimoto’s hypothyroidism is an autoimmune disease, which is mainly treated by thyroxine replacement therapy, while thyroid cancer is the most common malignant tumor of the thyroid gland, and the main treatments include surgery, radionuclide therapy and chemotherapy.
Hashimoto’s hypothyroidism is an autoimmune disease, in which autoantibodies against the thyroid gland are present in the patient’s serum, leading to destruction of the thyroid gland by inflammation. Clinical manifestations are mainly chills, drowsiness, oligosweat, constipation and other symptoms of hypometabolism and decreased excitability. Currently, there is no treatment for the cause of hypothyroidism, and thyroxine replacement therapy is the main treatment for hypothyroidism.
Thyroid cancer is the most common malignant tumor of the thyroid gland, mainly including papillary carcinoma, follicular adenocarcinoma, medullary carcinoma and undifferentiated carcinoma. The main clinical manifestation of thyroid cancer is mass in the thyroid gland, and those with lymph node metastasis may have swelling of lymph nodes in the corresponding area, and those with lung and bone metastasis may have the manifestation of corresponding organ involvement.
At present, the main treatments for thyroid cancer include surgery, radionuclide treatment and chemotherapy.
It is worth noting that Hashimoto’s hypothyroidism has the possibility of malignant changes, so patients need to have regular checkups and consult the doctor when there are changes in their conditions to avoid delaying treatment.